-
Symbol
-
SYRS on OTC
-
Investment type
-
Equity / Common Stock, $0.001 par value per share
-
Latest Disclosed Shares Owned
-
707,114 shares
-
Security Ownership %
-
2.6%
Samsara BioCapital, L.P. ownership in Syros Pharmaceuticals, Inc. Common Stock, $0.001 par value per share (SYRS)
27 Mar 2025 - Samsara BioCapital, L.P. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 707,114 shares of Syros Pharmaceuticals, Inc. Common Stock, $0.001 par value per share (SYRS).
This represents 2.6% ownership of the company.
This is the first filing by Samsara BioCapital, L.P. disclosing ownership of Syros Pharmaceuticals, Inc. Common Stock, $0.001 par value per share (SYRS).